A genetic engineering lab seeks to determine how well their new CRISPR-Cas9 procedure works when editing genes in specific cells (lymphocyte cells) to remove chronic leukemia risk-associated mutations. They aim to target eight mutations that are present in a lymphocyte cell. In previous trials, they found that their genome editing procedure could successfully edit a single site in a single cell 82% of the time. 2B. (i) Based on this information, estimate the probability that they can successfully edit eight target mutations in one lymphocyte cell. 2B. (ii) Estimate the probability that they can successfully edit all eight target mutations in at least one cell in a pool of five lymphocytes